In parallel, it was reported that TNFR2+ Tregs were abnormally located in human and mouse tumors and that their activities inhibited immune surveillance, leading to elevated tumor aggressiveness [31,32,33,34,35,36,37]. Here, TNFRSF1B is linked to neoplasm.